These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 8386902

  • 21. Phorbol ester-induced dermal inflammation in mice: evaluation of inhibitors of 5-lipoxygenase and antagonists of leukotriene B4 receptor.
    Rao TS, Yu SS, Djuric SW, Isakson PC.
    J Lipid Mediat Cell Signal; 1994 Sep; 10(3):213-28. PubMed ID: 7812673
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Contributions of thromboxane and leukotrienes to PAF-induced impairment of lung function in the rat.
    Uhlig S, Wollin L, Wendel A.
    J Appl Physiol (1985); 1994 Jul; 77(1):262-9. PubMed ID: 7961243
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Pharmacologic modulation of PAF-induced mortality in mice.
    Carlson RP, O'Neill-Davis L, Chang J.
    Agents Actions; 1987 Aug; 21(3-4):379-81. PubMed ID: 3120513
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Granulocyte-macrophage colony-stimulating factor increases the synthesis of leukotriene B4 by human neutrophils in response to platelet-activating factor. Enhancement of both arachidonic acid availability and 5-lipoxygenase activation.
    McColl SR, Krump E, Naccache PH, Poubelle PE, Braquet P, Braquet M, Borgeat P.
    J Immunol; 1991 Feb 15; 146(4):1204-11. PubMed ID: 1846895
    [Abstract] [Full Text] [Related]

  • 30. Autocrine enhancement of leukotriene synthesis by endogenous leukotriene B4 and platelet-activating factor in human neutrophils.
    McDonald PP, McColl SR, Braquet P, Borgeat P.
    Br J Pharmacol; 1994 Mar 15; 111(3):852-60. PubMed ID: 8019762
    [Abstract] [Full Text] [Related]

  • 31. Role of platelet-activating factor and eicosanoids during endotoxin-induced lung injury in pigs.
    Olson NC, Joyce PB, Fleisher LN.
    Am J Physiol; 1990 Jun 15; 258(6 Pt 2):H1674-86. PubMed ID: 2163217
    [Abstract] [Full Text] [Related]

  • 32. Inhibition of the release of prostaglandins, thromboxanes, and leukotrienes from anaphylactic lungs by a platelet-activating factor (PAF) antagonist and its stimulation by PAF.
    Sirois P, Harczy M, Braquet P, Borgeat P, Maclouf J, Pradelles P.
    Adv Prostaglandin Thromboxane Leukot Res; 1987 Jun 15; 17B():1033-7. PubMed ID: 2823554
    [No Abstract] [Full Text] [Related]

  • 33. Inhibition by leukotriene inhibitors, and calcium and platelet-activating factor antagonists, of acute gastric and intestinal damage in arthritic rats and in cholinomimetic-treated mice.
    Rainsford KD.
    J Pharm Pharmacol; 1999 Mar 15; 51(3):331-9. PubMed ID: 10344635
    [Abstract] [Full Text] [Related]

  • 34. Platelet-activating factor synthesis by peritoneal mast cells and its inhibition by two quinoline-based compounds.
    Hogaboam CM, Donigi-Gale D, Shoupe TS, Bissonnette EY, Befus AD, Wallace JL.
    Br J Pharmacol; 1992 Jan 15; 105(1):87-92. PubMed ID: 1596692
    [Abstract] [Full Text] [Related]

  • 35. Stimulation of human polymorphonuclear leukocytes by leukotriene B4 and platelet-activating factor: an ultrastructural and pharmacological study.
    Rossi AG, MacIntyre DE, Jones CJ, McMillan RM.
    J Leukoc Biol; 1993 Feb 15; 53(2):117-25. PubMed ID: 8383164
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Anti-inflammatory activities of LDP-392, a dual PAF receptor antagonist and 5-lipoxygenase inhibitor.
    Qian C, Hwang SB, Libertine-Garahan L, Eckman JB, Cai X, Scannell RT, Yeh CG.
    Pharmacol Res; 2001 Sep 15; 44(3):213-20. PubMed ID: 11529688
    [Abstract] [Full Text] [Related]

  • 38. Platelet-activating factor and arachidonic acid metabolites mediate tumor necrosis factor and eicosanoid kinetics and cardiopulmonary dysfunction during bacteremic shock.
    Quinn JV, Slotman GJ.
    Crit Care Med; 1999 Nov 15; 27(11):2485-94. PubMed ID: 10579269
    [Abstract] [Full Text] [Related]

  • 39. Role of lipoxygenase metabolites in platelet-activating factor- and antigen-induced bronchial hyperresponsiveness and eosinophil infiltration.
    Seeds EA, Kilfeather S, Okiji S, Schoupe TS, Donigi-Gale D, Page CP.
    Eur J Pharmacol; 1995 Dec 07; 293(4):369-76. PubMed ID: 8748690
    [Abstract] [Full Text] [Related]

  • 40. The platelet-independent release of thromboxane A2 by Paf-acether from guinea-pig lungs involves mechanisms distinct from those for leukotriene.
    Lefort J, Rotilio D, Vargaftig BB.
    Br J Pharmacol; 1984 Jul 07; 82(3):565-75. PubMed ID: 6430375
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.